LOGIN  |  REGISTER
Surmodics
Assertio

Amwell CEO Roy Schoenberg to Speak at Stanford Disability & Telehealth Conference

May 16, 2024 | Last Trade: US$0.41 0.001 0.25

Boston, May 16, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in hybrid care enablement, today announced its Co-CEO and President, Roy Schoenberg, M.D., M.P.H., will speak at the Disability & Telehealth Conference at 12:15 PST on Saturday, May 18. The virtual conference explores barriers to telehealth enhancement for those with disabilities and the innovative solutions underway to advance healthcare accessibility.

Schoenberg will participate in the virtual panel, “Technology and Bold Solutions for Accessible Telehealth.” The session will focus on big tech’s role in driving innovations to meet the unique needs of patients with disabilities and will highlight the strategies and approaches that can fill care and accessibility gaps and improve health equity. Schoenberg will be joined by leaders from Stanford Medicine, Stanford Health Care, Zoom and Apple.

“The one in four adults in the U.S. who live with a disability that prevents them from accessing healthcare deserve better from the industry that is essential for their vitality,” said Schoenberg. “Virtual care is a bridge that can connect individuals to the care they need, helping to overcome physical, societal, and communication barriers and a lack of accessible medical equipment or transportation. I’m glad to represent Amwell in this important conversation that’s increasing prioritization for healthcare to become more equitable and inclusive for all.”

Amwell solutions prioritize improving access to quality healthcare for everyone, including those with disabilities. Patients can access care from anywhere with standard cellular coverage or internet connection, reducing the need to travel to in-person appointments and check-ins. Language and communication barriers are addressed with Interpreter Services and accessibility features enabled on Amwell Converge™, a WCAG-conformant platform.

To learn more and register for the Disability & Telehealth Conference, click here.

About Amwell  

Amwell is a leading hybrid care enablement platform in the United States and globally, connecting and enabling providers, payers, patients, and innovators to deliver greater access to more affordable, higher quality care. Amwell believes that hybrid care delivery will transform healthcare. We offer a single, comprehensive platform to support all digital health needs from urgent to acute and post-acute care, as well as chronic care management and healthy living. With nearly two decades of experience, Amwell powers the digital care of more than 50 health plans, which collectively represent more than 100 million covered lives, and many of the nation’s largest health systems. For more information, please visit https://business.amwell.com/.

©2024 American Well Corporation. All rights reserved. Amwell®, SilverCloud®, ConvergeTM, CarepointTM and the Amwell Logo are registered trademarks or trademarks of American Well Corporation.  

Astria Therapeutics

Stock Quote

Featured Stock

Cue Biopharma

Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...

CLICK TO LEARN MORE

Featured Stock

Chimerix

Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB